These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25931806)

  • 21. Effectiveness of acupuncture at acupoint BL1 (Jingming) in comparison with artificial tears for moderate to severe dry eye disease: a randomized controlled trial.
    Zhang X; Zhang B; Peng S; Zhang G; Ma J; Zhu W
    Trials; 2022 Jul; 23(1):605. PubMed ID: 35897025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Taufon use in myopic contact lens wearers].
    Naumenko VV; Pogosian MA; Sergeev VP
    Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized controlled trial on the efficacy and safety of autologous serum eye drops in dry eye syndrome.
    Zheng N; Zhu SQ
    World J Clin Cases; 2023 Oct; 11(28):6774-6781. PubMed ID: 37901024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Prolonged Reading on Dry Eye.
    Karakus S; Agrawal D; Hindman HB; Henrich C; Ramulu PY; Akpek EK
    Ophthalmology; 2018 Oct; 125(10):1500-1505. PubMed ID: 29705055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the clinical efficacy of preserved and preservative-free hydroxypropyl methylcellulose-dextran-containing eyedrops.
    Safarzadeh M; Azizzadeh P; Akbarshahi P
    J Optom; 2017; 10(4):258-264. PubMed ID: 27989693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase 2 randomized, double-masked, placebo-controlled study of a novel integrin antagonist (SAR 1118) for the treatment of dry eye.
    Semba CP; Torkildsen GL; Lonsdale JD; McLaurin EB; Geffin JA; Mundorf TK; Kennedy KS; Ousler GW
    Am J Ophthalmol; 2012 Jun; 153(6):1050-60.e1. PubMed ID: 22330307
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical Omega-3 Polyunsaturated Fatty Acids for the Treatment of Dry Eye - Results from a Pilot Randomized Controlled Masked-Observer Study.
    Kaercher T; Messmer EM; Berninger T; Huber-van der Velden KK; Geiger R; Cipriano-Bonvin P; Jacobi C
    Clin Ophthalmol; 2022; 16():4021-4031. PubMed ID: 36523849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration of efficacy and mechanism of 0.05% cyclosporine eye drops (II) monotherapy in allergic conjunctivitis-associated dry eye.
    Jiao X; Qi Y; Gao N; Zhang C; Zhao S; Yang R
    Eye (Lond); 2024 Apr; 38(5):937-944. PubMed ID: 37904000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel multi-ingredient supplement significantly improves ocular symptom severity and tear production in patients with dry eye disease: results from a randomized, placebo-controlled clinical trial.
    Gioia N; Gerson J; Ryan R; Barbour K; Poteet J; Jennings B; Sharp M; Lowery R; Wilson J; Morde A; Rai D; Padigaru M; Periman LM
    Front Ophthalmol (Lausanne); 2024; 4():1362113. PubMed ID: 38984118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Punctal occlusion for dry eye syndrome.
    Ervin AM; Law A; Pucker AD
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006775. PubMed ID: 28649802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term consumption of oral omega-3 and dry eye syndrome.
    Kangari H; Eftekhari MH; Sardari S; Hashemi H; Salamzadeh J; Ghassemi-Broumand M; Khabazkhoob M
    Ophthalmology; 2013 Nov; 120(11):2191-6. PubMed ID: 23642375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Combined Tear Film Therapy in Patients with Evaporative Dry Eye with Short Tear Film Breakup Time.
    Kim YH; Kang YS; Lee HS; Choi W; You IC; Yoon KC
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):635-643. PubMed ID: 28846481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osmoprotectants, carboxymethylcellulose and hyaluronic acid multi-ingredient eye drop: a randomised controlled trial in moderate to severe dry eye.
    Labetoulle M; Chiambaretta F; Shirlaw A; Leaback R; Baudouin C
    Eye (Lond); 2017 Oct; 31(10):1409-1416. PubMed ID: 28452989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of artificial tears containing trehalose and hyaluronic acid for dry eye disease in women aged 42-54 versus ≥ 55 years.
    Mateo-Orobia AJ; Del Prado Sanz E; Blasco-Martínez A; Pablo-Júlvez LE; Farrant S; Chiambaretta F
    Cont Lens Anterior Eye; 2023 Aug; 46(4):101845. PubMed ID: 37117131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose.
    Cohen S; Martin A; Sall K
    Clin Ophthalmol; 2014; 8():157-64. PubMed ID: 24403819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autologous Serum Eye Drops versus Artificial Tear Drops for Dry Eye Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Wang L; Cao K; Wei Z; Baudouin C; Labbé A; Liang Q
    Ophthalmic Res; 2020; 63(5):443-451. PubMed ID: 31884498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study.
    Celebi AR; Ulusoy C; Mirza GE
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):619-26. PubMed ID: 24566903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of topical cyclosporine 0.05% and osmoprotective lubricating eye drops in treating dry eye disease and inflammation.
    Mullick R; Annavajjhala S; Thakur P; Mohapatra A; Shetty R; D'Souza S
    Indian J Ophthalmol; 2021 Dec; 69(12):3473-3477. PubMed ID: 34826977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Phase II, Multicenter, Randomized, Placebo-Controlled, Double-Masked Trial of a Topical Estradiol Ophthalmic Formulation in Postmenopausal Women with Moderate-to-Severe Dry Eye Disease.
    Schmidl D; Szalai L; Kiss OG; Schmetterer L; Garhöfer G
    Adv Ther; 2021 Apr; 38(4):1975-1986. PubMed ID: 33710587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.